§483.25(k) Pain Management. The facility must ensure that pain management is provided to residents who require such services, consistent with professional standards of practice, the comprehensive person-centered care plan, and the residents' goals and preferences.
|
Observations:
Based on clinical record and select facility policy review and staff interview, it was determined that the facility failed to provide effective pain management and administer pain medication as prescribed by the physician and failed to attempt non-pharmacological interventions to alleviate pain prior to the administration of a narcotic pain medication prescribed on an as needed basis for one resident out of 12 sampled residents (Resident 2). Findings include: A review of the facility ' s policy titled " Pain Management " (last reviewed September 25, 2025) indicated that pain should be rated on intensity using a numerical scale (0-10) or a visual descriptor preferred by the resident. Nonpharmacological pain management interventions include but are not limited to adjusting the room temperature, smoothing linens, turning and repositioning, lessening any constrictive bandages or device, apply splinting, physical modalities, exercise to address stiffness, cognitive/behavioral intervention, and relaxation techniques. When treating pain, start with a drug appropriate to the residents ' current level of pain and progress by increasing the dose of that drug until the maximum benefit is obtained. Use the least invasive route of administration as possible. Prior to administering pain medications, attempt nonpharmacological interventions and reassess one hour after administration of any pain medication and document its effectiveness. A review of Resident 2 ' s clinical record revealed admission on December 12, 2019, with diagnoses including chronic pain (pain persisting longer than six months and associated with ongoing medical conditions), heart failure (a condition in which the heart cannot adequately pump blood to meet the body ' s needs), and constipation (difficulty or infrequent bowel movements, typically fewer than three per week).
A review of Resident 2 ' s physician orders revealed an order dated October 1, 2024, for Tylenol Oral Tablet 325 mg (Acetaminophen is used to reduce fever and relieve minor pain caused by conditions such as colds or flu, headache, muscle aches, arthritis, menstrual cramps and fevers), give 2 tablets by mouth every 4 hours as needed (PRN) for mild pain with a pain scale of 1 to 3 and an order for Tramadol HCl (an opioid agonist that may be used to treat moderate to moderately severe chronic pain in adults) Tab 50 mg, give 1 tablet orally every 12 hours as needed (PRN) for moderate pain related to pain, give for moderate pain or pain scale of 4 to 6. A review of the resident ' s electronic Medication Administration Record (eMAR is used to document medications taken by each resident) dated July 2025, revealed that the PRN Tramadol (opioid pain medication) ordered to manage moderate pain was administered on the following dates and times without any documented pain scale assessment or evidence that non-pharmacological interventions were attempted prior to administration.:
July 2, 2025, at 8:02 AM, July 3, 2025, at 8:29 AM, July 4, 2025, at 12:39 AM, July 9, 2025, at 8:19 AM, July 11, 2025, at 7:35 AM, July 24, 2025, at 8:14 AM, July 26, 2025, at 9:25 AM, and July 31, 2025, 2025, at 8:19 AM.
Further review of Resident 2 ' s clinical record revealed the eMAR dated August 2025, licensed nursing staff continued to administer PRN Tramadol (opioid pain medication) to manage moderate pain on the following dates and times without any documented pain scale assessment or evidence that non-pharmacological interventions were attempted prior to administration.:
August 1, 2025, at 8:02 AM, August 7, 2025, at 12:44 AM, August 10, 2025, at 12:16 PM, August 14, 2025, at 8:18 AM, August 15, 2025, at 8:24 AM, August 19, 2025, at 8:14 AM, August 21, 2025, at 8:15 AM, August 22, 2025, at 8:34 AM, August 23, 2025, at 7:51 AM, August 27, 2025, at 7:36 AM, August 30, 2025, at 10:38 AM, and August 31, 2025, at 8:39 AM. Further review revealed no documented evidence that the non-opioid medication (Tylenol) was offered or administered prior to giving the opioid (Tramadol), contrary to the physician ' s prescribed pain management plan.
The facility failed to assure licensed nursing staff assessed Resident 2 ' s reported pain level and recorded the corresponding numeric pain response prior to administering an opioid pain medication, Tramadol, and assure documented attempts of non-pharmacological interventions prior to administration of pain medications.
Additionally, the facility failed to assure licensed nursing staff administered a physician prescribed pain management regimen as prescribed, as evidence by administering an opioid medication, Tramadol, prior to a non-opioid medication, Tylenol.
The above findings were reviewed and confirmed by the Nursing Home Administrator (NHA) on October 16, 2025, at 1:30 PM.
28 Pa. Code 211.5(f)(ix) Medical records
28 Pa. Code 211.12 (c)(d)(1)(5) Nursing Services
| | Plan of Correction - To be completed: 12/02/2025
The facility acknowledges that documentation for Resident #2's PRN pain medication cannot be retroactively corrected.
All residents receiving PRN pain medication will have a documented pain scale assessment and evidence of non-pharmacological interventions attempted prior to medication administration, in accordance with facility policy.
All licensed nursing staff will receive in-service education on the facility's policy titled "Pain Management", emphasizing proper pain assessment, documentation, and implementation of non-pharmacological interventions.
The Nursing Home Administrator or designee will develop and implement a Quality Assurance study to monitor ongoing compliance. The QA study will include regular audits of pain management documentation to ensure pain scale assessments are completed prior to PRN administration x 6 months. In addition, non-pharmacological interventions are attempted and documented prior to medication use. Results of the QA study will be reviewed during the monthly QA committee meetings, and continued monitoring will occur until substantial compliance is achieved and sustained.
|
|